A virus once considered peripheral to European life has quietly embedded itself across twelve nations, with health authorities in Stockholm sounding the alarm over a transmission season that has already outpaced the last. West Nile virus, carried by mosquitoes long at home on the continent, now touches ninety-nine regions from Albania to Spain — and with no vaccine or cure to offer, the only answer lies in the ancient, unglamorous work of prevention. The expansion arrives alongside a second reckoning: an invasive mosquito species has doubled its European footprint in a single decade, suggestin
West Nile virus spreads across 12 European countries as health agencies urge stronger mosquito control
West Nile virus infections across 12 European countries can cause severe neurological complications including encephalitis and meningitis, with potential for fatal outcomes in extreme cases.
Europe's mosquito-control infrastructure is not keeping pace with the virus's expansion
Mark
Why does West Nile virus suddenly matter now? It's been around for decades.
Mimi
It hasn't been around Europe for decades—that's the point. It's expanding its range, and it's doing so faster than the systems designed to stop it. The virus itself hasn't changed. What's changed is that the mosquitoes carrying it are thriving in warmer conditions, and we've built no real defense.
Mark
But most people who get it recover fine, right?
Mimi
Most do. But "most" isn't everyone. In severe cases, it attacks the brain. Encephalitis, meningitis. People end up in comas. Some die. And we have no way to treat it once you're infected—only supportive care in a hospital bed.
Mark
So what's the solution? Kill all the mosquitoes?
Mimi
That's the dream, but it's not realistic. Culex mosquitoes are already everywhere in Europe. The real work is reducing their breeding grounds, monitoring where they're spreading, and catching new invasions early. The Asian tiger mosquito is the warning sign—it's doubled its range in twelve years. If we don't act now, we'll be managing dengue and chikungunya across Europe within a decade.
Mark
Why is this a European problem and not a global one?
Mimi
It is global. But Europe is watching it happen in real time right now. Italy and Greece are dealing with hundreds of cases this summer. The question is whether that's a wake-up call or just the new normal.
Mark
What would actually work?
Mimi
Coordination. Mosquito monitoring networks. Funding for vector control. Public awareness so people understand why standing water matters. And environmental approaches that don't just spray poison everywhere. It's unglamorous work, but it's the only thing that stops these viruses from spreading.
Il Polso
- Twelve European countries have confirmed locally-acquired West Nile virus cases in 2026, a sharp jump from nine countries at the same point last year, with twenty-one regions reporting the virus for the very first time.
- Italy and Greece are carrying the heaviest burden — 311 and 157 cases respectively — but the virus has now been detected across ninety-nine separate regions, signaling a geographic spread that is widening with each passing week.
- The virus's most dangerous form attacks the nervous system, triggering encephalitis, meningitis, and coma, yet no approved vaccine or targeted treatment exists, leaving doctors with only supportive care for the most critically ill.
- The Asian tiger mosquito — capable of spreading dengue and chikungunya — has colonized sixteen European countries, up from eight just twelve years ago, compounding the threat well beyond West Nile virus alone.
- Europe's top vector-disease official is calling for a coordinated continental strategy combining surveillance, public education, and targeted mosquito control, with the transmission season already at its peak and the window for intervention closing fast.
A virus once considered peripheral to European life has quietly embedded itself across twelve nations, with health authorities in Stockholm sounding the alarm over a transmission season that has already outpaced the last. West Nile virus, carried by mosquitoes long at home on the continent, now touches ninety-nine regions from Albania to Spain — and with no vaccine or cure to offer, the only answer lies in the ancient, unglamorous work of prevention. The expansion arrives alongside a second reckoning: an invasive mosquito species has doubled its European footprint in a single decade, suggesting that the continent's disease landscape is being redrawn faster than its institutions are prepared to respond.
A mosquito-borne virus long regarded as a distant concern has quietly taken hold across Europe. On Friday, health officials in Stockholm confirmed that twelve countries have documented locally-acquired West Nile virus cases in 2026 — a significant acceleration from the nine countries affected at the same point last year. The virus has now been detected across ninety-nine regions, twenty-one of which are reporting it for the first time.
For most people, infection produces flu-like symptoms: fever, fatigue, body aches. But in severe cases, the virus crosses into the nervous system, causing encephalitis, meningitis, tremors, and coma. There is no vaccine and no specific treatment. Physicians can only manage symptoms and provide intensive care for those most critically ill.
Italy and Greece have borne the greatest burden, with 311 and 157 confirmed cases respectively. The twelve affected nations stretch across much of the continent — from Albania and North Macedonia in the southeast to France, Germany, and the Netherlands in the west. Celine Gossner, who leads the European Centre for Disease Prevention and Control's vector-borne disease division, warned that mosquito-control infrastructure is not keeping pace with the virus's spread, and called for a unified strategy combining surveillance, public education, and targeted intervention — all while protecting the broader environment.
The concern does not end with West Nile virus. The Asian tiger mosquito, an invasive species capable of transmitting dengue and chikungunya, has now established itself in sixteen European countries — double the eight it occupied just twelve years ago. That rapid expansion is a signal of how quickly the continent's disease landscape can shift. With transmission peaking between July and September and no medical countermeasures available, prevention through sustained, cross-border mosquito control remains the only meaningful tool — and the question of whether governments will treat it as such grows more urgent by the week.
A mosquito-borne virus that most people think of as a distant threat has quietly established itself across the European continent. On Friday, health officials in Stockholm announced that twelve countries have now documented locally-acquired cases of West Nile virus during 2026 alone—a sharp acceleration that has prompted urgent calls for coordinated action across the region.
The virus spreads through the bite of infected mosquitoes, typically Culex species that have long inhabited Europe. For most people who contract it, the illness resembles the flu: fever, body aches, fatigue. But West Nile virus carries a darker potential. In severe cases, it crosses into the nervous system, causing tremors, high fevers, comas, and encephalitis—a swelling of brain tissue that can be fatal. Meningitis is another serious complication. There is no vaccine to prevent infection and no specific drug to treat it. Doctors can only manage symptoms and provide intensive care for the sickest patients.
The twelve affected countries span much of Europe: Albania, Austria, France, Germany, Greece, Italy, Kosovo, the Netherlands, North Macedonia, Romania, Serbia, and Spain. Across these nations, the virus has been detected in ninety-nine separate regions. Italy and Greece have borne the heaviest burden, with 311 and 157 confirmed cases respectively. What makes this year particularly concerning is that twenty-one of these regions are reporting West Nile virus for the first time. A year ago, in August 2025, only nine European countries across sixty-seven regions had documented cases during the same period. The geographic spread has widened significantly.
Celine Gossner, who heads the European Centre for Disease Prevention and Control's division on food-, water-, vector-borne and zoonotic diseases, framed the situation plainly: Europe's mosquito-control infrastructure is not keeping pace with the virus's expansion. She called for a comprehensive strategy that combines mosquito surveillance, public education, and targeted control measures—all while minimizing harm to the broader environment. The timing matters. West Nile virus transmission peaks between July and September, when mosquito populations are at their highest. The season typically runs from late spring through autumn, meaning the window for intervention is narrow.
The underlying problem extends beyond West Nile virus alone. The Culex mosquitoes that carry it are already widespread across Europe and difficult to eliminate. But a second threat is gaining ground: the Asian tiger mosquito, an invasive species that can transmit dengue fever and chikungunya. Twelve years ago, this mosquito was established in eight European countries. Today it has colonized sixteen. That doubling in range over a single decade signals how quickly invasive species can reshape the disease landscape when conditions favor them.
The absence of approved vaccines or specific treatments means prevention is the only real tool available. That prevention depends almost entirely on reducing mosquito populations and limiting human exposure—work that requires sustained effort, funding, and coordination across borders. The question now is whether European governments will treat this as an urgent priority or allow the virus to continue its slow march northward and westward across the continent.
Citazioni salienti
Europe needs to strengthen its mosquito-control capacity through close cooperation and an integrated approach combining mosquito monitoring, community engagement, and targeted control solutions— Celine Gossner, European Centre for Disease Prevention and Control
Vuoi la storia completa?
Leggi l'originale su The Star ↗
Health & Medicine